OpenAlex konusu

Myasthenia Gravis and Thymoma

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 1.826 eser 36 yazar konusu

Çalışmalar

1.826 eser

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.9%
Özet henüz yok.
- BAKİ DOĞAN
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.9%
Özet henüz yok.
- SEDAT ŞEN
- SİBEL GAZİOĞLU
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 2017
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.9%
Özet henüz yok.
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors 2014
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%
Özet henüz yok.
- SUAT ERUS
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database 2012
OpenAlex üst %1 OpenAlex 99.6%
Özet henüz yok.
- AYTEN KAYI CANGIR
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts 2011
YÖKSİS SJR Q2 OpenAlex üst %10 OpenAlex 93.9%
BACKGROUND: Histopathological grading of ependymoma has been controversial with respect to its reproducibility and clinical significance. In a 3-phase study, we reviewed the pathology of 229 intracranial ependymomas from European trial cohorts of infants (2 trials - SFOP/CNS9204) and older children (2 trials - AIEOP/C…
- MEHMET KOÇAK
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis 2019
YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %1 OpenAlex 99.6%
INTRODUCTION: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of REGAIN, evaluating eculizumab's long-term safety and efficacy. METHODS:…
- MURAT TERZİ
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis 2019
YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %1 OpenAlex 99.6%
INTRODUCTION: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody-positive refractory generalized myasthenia gravis (gMG; REGAIN; NCT01997229). We report an interim analysis of an open-label extension of REGAIN, evaluating eculizumab's long-term safety and efficacy. METHODS:…
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors 2014
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.8%
Özet henüz yok.
- SUAT ERUS
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma 2016
YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.4%
Özet henüz yok.
- CANSEL ATİNKAYA BAYTEMİR
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma 2016
OpenAlex üst %1 OpenAlex 99.3%
Özet henüz yok.
- AYTEN KAYI CANGIR
Long term outcome of patients with spinal myxopapillary ependymoma treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network 2015
YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.3%
BACKGROUND: Spinal myxopapillary ependymomas (MPEs) are slowly growing ependymal gliomas with preferential manifestation in young adults. The aim of this study was to assess the outcome of patients with MPE treated with surgery, radiotherapy (RT), and/or chemotherapy. METHODS: The medical records of 183 MPE patients (…
- YAVUZ ANACAK

Akademisyenler

36 akademisyen